Ed Biotech: Announcement on the progress of share repurchases
Ed Biotech: An indicative announcement on the 2023 Restricted Stock Incentive Plan granted for the first time to lift the sales restriction period and lift the listing and circulation of restricted shares
Ed Biotech: Announcement on the repurchase and cancellation of some restricted stocks in the 2023 Restricted Stock Incentive Plan
Ed Biotech: Announcement on the 2023 Restricted Stock Incentive Plan for the first time to grant the first achievement of lifting the sales restriction period and lifting the sales restriction conditions
Ed Biotech: Supervisory Board\'s Review Opinions on the Company\'s 2023 Restricted Stock Incentive Plan for the First Time Granting the First List of Incentives to Lift the Sales Restriction Period
Ed Biotech: Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. independent financial advisory report on matters relating to the company\'s 2023 restricted stock incentive plan granted the first time to lift the sales restriction period and the achievement of the conditions for lifting the sales restrictions
Ed Biotech: Legal Opinion of Shanghai AllBright Law Firm on the Company\'s 2023 Restricted Stock Incentive Plan for the First Time Granting of Some Restricted Stocks, the First Release of the Sales Restriction Period, Achievements of the Conditions of Cancellation of Sales Restrictions, and Matters Related to the Repurchase and Cancellation of Some Restricted Shares
Ed Biotech: Announcement on the progress of share repurchases
Ed Biotech: Announcement on the progress of share repurchases
Ed Biotech: Progress announcement on share repurchase ratio reaching 1%
Ed Biotech: Announcement on the progress of share repurchases
Amoy Diagnostics: Announcement regarding the progress of share repurchase.
Amoy Diagnostics: Announcement on Adjusting Relevant Matters of Restricted Stock Incentive Plan in 2023
Amoy Diagnostics: Legal Opinion on Adjustment of Repurchase Price in 2023 Restricted Stock Incentive Plan of Amoy Diagnostics Biomedical Technology Co., Ltd.
Amoy Diagnostics: Announcement regarding the progress of share repurchase.
Amoy Diagnostics: Notice regarding the disclosure of the abbreviated equity change report.
Amoy Diagnostics: Simplified Equity Change Report
Amoy Diagnostics: Announcement on the progress of share repurchases
Amoy Diagnostics: Announcement on the implementation of the distribution of rights in 2023
Amoy Diagnostics: Announcement on the completion of partial restricted stock repurchases and cancellations
No Data